Effect and Process Evaluation of the SME Tool

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status: Not yet enrolling

Conditions: Sick-listed Employees

Treatments: Other: The SME tool

Study type: Interventional

Funder types: Other

Identifiers

NCT06330415

25603

Details and patient eligibility

About

A web-based tool has been developed to help small and medium-sized businesses support employees returning to work after sick-leave. A six-month trial is conducted, randomly assigning employer-employee dyads to either use the tool or receive standard care. The primary aim is to evaluate its impact on employee satisfaction with return-to-work support.

Enrollment: 404 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Employees at study enrolment should:

• be of working age (18-65 years);
• have a fixed or temporary employment contract at a SME (≤ 250 employees), with a minimum of 6 months remaining in their contract;
• be currently sick-listed or partially sick-listed (≤8 weeks), with a risk of long-term absenteeism, based on the likelihood of the duration of sickness absence exceeding two months as assessed by their occupational physician;
• be able to understand and read Dutch sufficiently, in order to complete the questionnaires.

The employer of the participating employee will be included. At time of study entry, the employer should be:

• an employer, supervisor, (case)manager or HR manager of a SME (≤ 250 employees). In this study, the employer is appointed by the employee and refers to the person who is the direct supervisor, in direct contact with the employee, and thus the person who offers the RTW support to the employee;
• able to understand and read Dutch sufficiently, in order to use the intervention and complete the questionnaires.

Exclusion criteria

• Not have a colleague who is already participating in the study.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

404 participants in 2 patient groups

Intervention group

Experimental group

Description:

Unlimited access to the SME tool.

Treatment:

Other: The SME tool

Control group

No Intervention group

Description:

Care as usual by the occupational health service.